NO20012100L - Pyrano-, piperidino- og tiopyranoforbindelser og fremgangsmåter ved anvendelse - Google Patents
Pyrano-, piperidino- og tiopyranoforbindelser og fremgangsmåter ved anvendelseInfo
- Publication number
- NO20012100L NO20012100L NO20012100A NO20012100A NO20012100L NO 20012100 L NO20012100 L NO 20012100L NO 20012100 A NO20012100 A NO 20012100A NO 20012100 A NO20012100 A NO 20012100A NO 20012100 L NO20012100 L NO 20012100L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- thiopyrano
- pyrano
- piperidino
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18169098A | 1998-10-28 | 1998-10-28 | |
| US09/421,862 US6191140B1 (en) | 1998-10-28 | 1999-10-20 | Pyrano, piperidino, and thiopyrano compounds and methods of use |
| PCT/US1999/025373 WO2000024743A1 (en) | 1998-10-28 | 1999-10-28 | Pyrano, piperidino, and thiopyrano compounds and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20012100D0 NO20012100D0 (no) | 2001-04-27 |
| NO20012100L true NO20012100L (no) | 2001-06-14 |
| NO318628B1 NO318628B1 (no) | 2005-04-18 |
Family
ID=26877422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012100A NO318628B1 (no) | 1998-10-28 | 2001-04-27 | Pyrano-, piperidino- og tiopyranoforbindelser, farmasoytiske sammensetninger inneholdende det samme og anvendelse av forbindelsene |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6191140B1 (no) |
| EP (1) | EP1124828B1 (no) |
| JP (1) | JP2002528454A (no) |
| KR (1) | KR20010085975A (no) |
| CN (1) | CN1335846A (no) |
| AT (1) | ATE382620T1 (no) |
| AU (1) | AU764163B2 (no) |
| BG (1) | BG105524A (no) |
| BR (1) | BR9914688A (no) |
| CA (1) | CA2348576A1 (no) |
| CZ (1) | CZ20011480A3 (no) |
| DE (1) | DE69937895T2 (no) |
| ES (1) | ES2299272T3 (no) |
| HK (1) | HK1041877A1 (no) |
| HU (1) | HUP0104146A3 (no) |
| NO (1) | NO318628B1 (no) |
| NZ (1) | NZ511041A (no) |
| PL (1) | PL347552A1 (no) |
| SK (1) | SK5242001A3 (no) |
| TR (1) | TR200101140T2 (no) |
| WO (1) | WO2000024743A1 (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6265417B1 (en) | 1997-12-18 | 2001-07-24 | Abbott Laboratories | Potassium channel openers |
| US6593335B1 (en) | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
| US6642222B2 (en) * | 1998-10-28 | 2003-11-04 | Abbott Laboratories | Pyrano, piperidino, and thiopyrano compounds and methods of use |
| CA2378936A1 (en) * | 1999-08-03 | 2001-02-08 | Abbott Laboratories | Potassium channel openers |
| US6538004B2 (en) * | 2000-03-03 | 2003-03-25 | Abbott Laboratories | Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| JP2004505109A (ja) * | 2000-08-02 | 2004-02-19 | アストラゼネカ・アクチエボラーグ | 置換された１，４−ジヒドロピリジンの不斉合成法 |
| WO2003011869A1 (en) * | 2001-07-30 | 2003-02-13 | Abbott Laboratories | Radioligands and their use for identifying potassium channel modulators |
| US6632418B2 (en) * | 2001-07-30 | 2003-10-14 | Abbott Laboratories | Radioligands and their use for identifying potassium channel modulators |
| US20030153773A1 (en) * | 2002-02-14 | 2003-08-14 | Wayne Gregory S. | Process for the production of dihydropyridines |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4321384A (en) | 1981-02-27 | 1982-03-23 | American Home Products Corporation | Antihypertensive agents |
| GB2093834B (en) | 1981-02-27 | 1984-08-15 | American Home Prod | Antihypertensive agents |
| US4551534A (en) | 1984-03-30 | 1985-11-05 | American Home Products Corporation | Aralkyl or aryloxyalkyl 1,7-naphthyridine-3-carboxylic acid esters |
| AU6042686A (en) | 1985-07-29 | 1987-02-05 | American Home Products Corporation | 1,4,5,6,7,8-hexahydro-(substituted) phenyl-1,7- napthyridine-3-carboxylic acid derivatives |
| US4596873A (en) | 1985-07-29 | 1986-06-24 | American Home Products Corporation | 1,4,5,6,7,8-Hexahydro-2-alkyl-4-aryl-5-oxo-1,7-naphthyridine-3-carboxylic acid aromatic esters and pharmaceutically acceptable acid addition salts thereof useful as antihypertensive agents |
| US4618678A (en) | 1985-07-29 | 1986-10-21 | American Home Products Corporation | 4-(2,3-dichloro-6-fluorophenyl)-1,4,5,6,7,8-hexahydro-2-methyl-5-oxo-1,7-naphthyridine-3-carboxylic acid 2-(2,3-dichlorophenoxy)ethyl ester |
| GB9220570D0 (en) * | 1991-10-21 | 1992-11-11 | Ici Plc | Therapeutic agent |
| CA2080949A1 (en) | 1991-10-21 | 1993-04-22 | Cyrus John Ohnmacht | Therapeutic agents |
| GB9318935D0 (en) * | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
| DE4424678A1 (de) | 1994-07-13 | 1996-01-18 | Bayer Ag | Dioxo-thiopyrano-pyridin-carbonsäure-derivate |
| US6593335B1 (en) * | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
| HUP0100112A3 (en) * | 1997-12-18 | 2004-05-28 | Abbott Lab | Fused pyridine derivatives having potassium chanel opening activity and their use |
| JP2002528452A (ja) * | 1998-10-28 | 2002-09-03 | アボット・ラボラトリーズ | ジヒドロピリジン化合物および使用方法 |
-
1999
- 1999-10-20 US US09/421,862 patent/US6191140B1/en not_active Expired - Fee Related
- 1999-10-28 JP JP2000578313A patent/JP2002528454A/ja active Pending
- 1999-10-28 KR KR1020017005347A patent/KR20010085975A/ko not_active Application Discontinuation
- 1999-10-28 AT AT99960168T patent/ATE382620T1/de not_active IP Right Cessation
- 1999-10-28 SK SK524-2001A patent/SK5242001A3/sk unknown
- 1999-10-28 BR BR9914688-6A patent/BR9914688A/pt not_active IP Right Cessation
- 1999-10-28 CN CN99815020A patent/CN1335846A/zh active Pending
- 1999-10-28 TR TR2001/01140T patent/TR200101140T2/xx unknown
- 1999-10-28 WO PCT/US1999/025373 patent/WO2000024743A1/en active IP Right Grant
- 1999-10-28 HU HU0104146A patent/HUP0104146A3/hu unknown
- 1999-10-28 AU AU17095/00A patent/AU764163B2/en not_active Ceased
- 1999-10-28 CZ CZ20011480A patent/CZ20011480A3/cs unknown
- 1999-10-28 NZ NZ511041A patent/NZ511041A/xx unknown
- 1999-10-28 EP EP99960168A patent/EP1124828B1/en not_active Expired - Lifetime
- 1999-10-28 ES ES99960168T patent/ES2299272T3/es not_active Expired - Lifetime
- 1999-10-28 CA CA002348576A patent/CA2348576A1/en not_active Abandoned
- 1999-10-28 PL PL99347552A patent/PL347552A1/xx not_active Application Discontinuation
- 1999-10-28 DE DE69937895T patent/DE69937895T2/de not_active Expired - Lifetime
-
2001
- 2001-04-27 NO NO20012100A patent/NO318628B1/no not_active IP Right Cessation
- 2001-05-19 BG BG105524A patent/BG105524A/bg unknown
-
2002
- 2002-02-19 HK HK02101208.4A patent/HK1041877A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69937895T2 (de) | 2009-01-02 |
| US6191140B1 (en) | 2001-02-20 |
| HUP0104146A2 (hu) | 2002-04-29 |
| PL347552A1 (en) | 2002-04-08 |
| AU764163B2 (en) | 2003-08-14 |
| HUP0104146A3 (en) | 2002-10-28 |
| NZ511041A (en) | 2003-03-28 |
| BR9914688A (pt) | 2001-10-02 |
| JP2002528454A (ja) | 2002-09-03 |
| TR200101140T2 (tr) | 2002-07-22 |
| AU1709500A (en) | 2000-05-15 |
| BG105524A (bg) | 2001-12-29 |
| CA2348576A1 (en) | 2000-05-04 |
| ES2299272T3 (es) | 2008-05-16 |
| KR20010085975A (ko) | 2001-09-07 |
| CZ20011480A3 (cs) | 2001-08-15 |
| NO20012100D0 (no) | 2001-04-27 |
| ATE382620T1 (de) | 2008-01-15 |
| WO2000024743A1 (en) | 2000-05-04 |
| EP1124828B1 (en) | 2008-01-02 |
| EP1124828A1 (en) | 2001-08-22 |
| HK1041877A1 (zh) | 2002-07-26 |
| CN1335846A (zh) | 2002-02-13 |
| DE69937895D1 (de) | 2008-02-14 |
| SK5242001A3 (en) | 2001-12-03 |
| NO318628B1 (no) | 2005-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03007140A (es) | Derivados de carbolina. | |
| AU2002223126A1 (en) | Enclosed nickel-zinc primary battery, its anode and production methods for them | |
| YU19499A (sh) | Benzonaftiridini kao bronhijalni terapeutici | |
| MXPA02012076A (es) | Compuestos quimicos. | |
| MXPA02012659A (es) | Derivados de pirazindiona condensados. | |
| HK1041562A1 (en) | Electrolyte for lithium secondary battery and lithium secondary battery using the same. | |
| NO20012100L (no) | Pyrano-, piperidino- og tiopyranoforbindelser og fremgangsmåter ved anvendelse | |
| AU2233702A (en) | An electrochemical cell | |
| DE60019121D1 (de) | Kaliumkanäleöffner | |
| NO20011209L (no) | Batteri med fast-elektrolytt og fremgangsmåte til fremstilling av dette | |
| EP1727546A4 (en) | METHODS AND PREPARATIONS FOR CELL PROTECTION AND TREATMENT OF DISEASES AND DISORDERS FOR OPTIMIZING THE INTRACELLULAR CONCENTRATION OF NAD | |
| CY1105765T1 (el) | Πυρανο πιπepιδιο και θειοπυρανο ενωσεις και μεθοδοι χρησης | |
| GB0006429D0 (en) | Electrochemical cell | |
| AU2001267724A1 (en) | Electrochemical cell | |
| DZ2292A1 (fr) | Méthode concernant l'immortalité des cellules. | |
| MXPA02012472A (es) | Compuestos quimicos. | |
| GB0006428D0 (en) | Electrochemical cell | |
| GB2380614B (en) | Electrochemical cells | |
| AU2001256998A1 (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
| AU2001251508A1 (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
| AU2001285637A1 (en) | Electrochemical cell, use of the electrochemical cell, and method for electrolytically contacting and electrochemically influencing surfaces | |
| DE50103547D1 (de) | Verwendung von sekundärem zellwandpolymer prokaryontischer mikroorganismen | |
| WO2006012222A3 (en) | Methods of treating smooth muscle cell disorders | |
| WO2003076588A8 (en) | Multiplexed cell transfection using coded carriers | |
| TR200402036T4 (tr) | (-)-Cis-2-(2-Klorofenil)-5, 7-Dihidroksi-8-[4R-(3S-Hidroksi-1-Metil) Piperidinil]-4H-1- Benzopiran-4-on'un psödopolimorfu |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |